Molecular diagnostics is being applied to an increasingly wide range of applications in infectious disease, oncology, and genetic disease diagnosis and screening, and to a number of emerging applications. The market for molecular diagnostics products totaled nearly $21bn in 2021. Following a projected downturn in 2022 and 2023 due to a decline in COVID-19 testing, the market is expected to return to growth in 2024. Drivers of the market will include adoption of new types of tests, expansion of target populations for molecular testing, and advances in the level of diagnostic testing services provided, particularly in developing countries.
This new report includes a discussion of products, current/forecast markets, competitors, and opportunities in the molecular diagnostics products markets for the US, 5 Euro (France, Germany, Italy, Spain, and UK), Japan, and Rest of World markets. The forecast range for this report is 2021-26.
This medical market and technology report provides a comprehensive discussion of the market for molecular diagnostics. This market consists of in vitro molecular diagnostics solutions, instrument systems, reagents, and services (maintenance and repair). Product segments included within this market comprise those used for the following clinical applications: blood screening, genetic testing, infectious disease, oncology, and other.
Markets covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets, which includes all other countries.
This new report includes a discussion of products, current/forecast markets, competitors, and opportunities in the molecular diagnostics products markets for the US, 5 Euro (France, Germany, Italy, Spain, and UK), Japan, and Rest of World markets. The forecast range for this report is 2021-26.
This medical market and technology report provides a comprehensive discussion of the market for molecular diagnostics. This market consists of in vitro molecular diagnostics solutions, instrument systems, reagents, and services (maintenance and repair). Product segments included within this market comprise those used for the following clinical applications: blood screening, genetic testing, infectious disease, oncology, and other.
Markets covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets, which includes all other countries.
This report provides the following useful information:
- Epidemiology of selected diseases
- Blood collection trends
- An overview of molecular diagnostics technology, including companion diagnostics
- Product portfolios offered by leading manufacturers
- In-depth market and competitive analyses
Table of Contents
Executive Summaryii. Market drivers and limitersiii. Technology trendsiv. Market leadersv. Competitive strategiesvi. Emerging competitionAPPENDIX: COMPANY LISTING
i. Molecular diagnostics market
vii. Methodology
1. Molecular Diagnostics Clinical Overview
2. Molecular Diagnostics Products
3. Molecular Diagnostics Market
